147 related articles for article (PubMed ID: 23494077)
1. A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model.
Rao B; Gao Y; Zhou Q; Xiao P; Xia S; Ma J; Luo J; Xiao T; Le S; Huang M; Wang J
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1015-23. PubMed ID: 23494077
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model.
Hu Z; Sun Y; Garen A
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8161-6. PubMed ID: 10393965
[TBL] [Abstract][Full Text] [Related]
3. Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer.
Hu Z; Garen A
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12180-5. PubMed ID: 11593034
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancer.
Hu Z; Li J
BMC Immunol; 2010 Oct; 11():49. PubMed ID: 20939894
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy.
Hu Z; Garen A
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9221-5. PubMed ID: 10922073
[TBL] [Abstract][Full Text] [Related]
6. Factor VII light chain-targeted lidamycin targets tissue factor-overexpressing tumor cells for cancer therapy.
Zhang Q; Liu XJ; Hu L; Liao DS; Zheng YB; Zhen YS; Song X
Int J Mol Med; 2012 Mar; 29(3):409-15. PubMed ID: 22108624
[TBL] [Abstract][Full Text] [Related]
7. Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells.
Liu FR; Bai S; Feng Q; Pan XY; Song SL; Fang H; Cui J; Yang JL
BMC Cancer; 2018 Nov; 18(1):1087. PubMed ID: 30419845
[TBL] [Abstract][Full Text] [Related]
8. Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors.
Li HJ; Everts M; Yamamoto M; Curiel DT; Herschman HR
Cancer Res; 2009 Jan; 69(2):554-64. PubMed ID: 19147569
[TBL] [Abstract][Full Text] [Related]
9. Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases.
Tada H; Maron DJ; Choi EA; Barsoum J; Lei H; Xie Q; Liu W; Ellis L; Moscioni AD; Tazelaar J; Fawell S; Qin X; Propert KJ; Davis A; Fraker DL; Wilson JM; Spitz FR
J Clin Invest; 2001 Jul; 108(1):83-95. PubMed ID: 11435460
[TBL] [Abstract][Full Text] [Related]
10. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models.
Nielsen LL; Gurnani M; Syed J; Dell J; Hartman B; Cartwright M; Johnson RC
Hum Gene Ther; 1998 Mar; 9(5):681-94. PubMed ID: 9551616
[TBL] [Abstract][Full Text] [Related]
11. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L
Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155
[TBL] [Abstract][Full Text] [Related]
12. [Ectopic expression and clinical significance of tissue factor/coagulation factor VII complex in colorectal cancer].
Tang JQ; Fan Q; Wan YL; Liu YC; Wang X; Wu T; Pan YS; Wu WH; Zhu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):531-6. PubMed ID: 19829668
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.
Cocco E; Varughese J; Buza N; Bellone S; Lin KY; Bellone M; Todeschini P; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Carrara L; Tassi R; Pecorelli S; Lockwood CJ; Santin AD
Clin Exp Metastasis; 2011 Oct; 28(7):689-700. PubMed ID: 21725665
[TBL] [Abstract][Full Text] [Related]
14. Immunization and immunotherapy for cancers involving infection by a human papillomavirus in a mouse model.
Li J; Sun Y; Garen A
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16232-6. PubMed ID: 12446839
[TBL] [Abstract][Full Text] [Related]
15. Development of a recombinant human IL-15·sIL-15Rα/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse model.
Zhao M; Luo M; Xie Y; Jiang H; Cagliero C; Li N; Ye H; Wu M; Hao S; Sun T; Yang H; Zhang M; Lin T; Lu H; Zhu J
Biomed Pharmacother; 2019 Apr; 112():108677. PubMed ID: 30798123
[TBL] [Abstract][Full Text] [Related]
16. [Construction of a recombinant adenovirus vector harboring human transforming growth factor-beta type II receptor-IgG1Fc fusion gene].
Jia L; Xue JX; Lu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2136-8. PubMed ID: 19114339
[TBL] [Abstract][Full Text] [Related]
17. [Construction of recombinant adenovirus vector expressing extracellular domain of TbetaR-II-RANTES fusion gene and its anti-tumor effects].
Wang XD; Liu H; Cao S; Li H; Ren XB; Hao XS
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):405-10. PubMed ID: 17974270
[TBL] [Abstract][Full Text] [Related]
18. Icon immunoconjugate treatment results in regression of red lesions in a non-human primate (Papio anubis) model of endometriosis.
Hufnagel D; Goetz TG; Hu Z; Nyachieo A; D'Hooghe T; Fazleabas A; Duleba A; Krikun G; Taylor HS; Lockwood CJ
Reprod Biol; 2018 Mar; 18(1):109-114. PubMed ID: 29422377
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
[TBL] [Abstract][Full Text] [Related]
20. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
Liu A; Hu P; Khawli LA; Epstein AL
Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
